Overview of Anti-platelet Drug Use in Ischemic Stroke Patients at UKI General Hospital in 2015

Djojosaputro, Mulyadi and Aritonang, Christina Roseville Lasma (2022) Overview of Anti-platelet Drug Use in Ischemic Stroke Patients at UKI General Hospital in 2015. Journal of Drug Delivery and Therapeutics, 12 (2). pp. 34-39. ISSN 2250 117

	Text OverviewofAntiplateletDrugUseinIschemicStroke.pdf Download (553kB)
	Text (Hasil_Turnitin) HasilTurnitinOverviewofAntiplateletDrugUseinIschemicStroke.pdf Download (1MB)

Abstract

Stroke is an acute neuro-deficit disease that occurs when there is a disturbance of cerebral blood flow. There are two kinds of stroke, hemorrhagic stroke and ischemic stroke. Ischemic stroke is a stroke that occurs due to the formation of thrombosis and emboli. Thrombosis and emboli block the bloodstream in small blood vessels or prominent blood vessels. Drugs that can cause disturbance to the hemostasis mechanism, such as antiplatelets, are usually used on stroke management. This study aims to know the types and amounts of antiplatelet drugs used on stroke ischemic patients in UKI General Hospital from January to December 2015. This research showed that stroke ischemic occurs more often at age 61 -70 (43%). There are no significant differences between bothgenders, the most common drugs are Aspilet 80 mg (22 times). For combination drugs, Clopidogrel with Aspilet is used more often than Clopidogrel with Ascardia.Keywords: stroke, thrombosis, antiplatelet

Actions (login required)

View Item